Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Uncovering the importance of lipofection for aptamer-mediated therapeutic oligonucleotide delivery in a HER2+ SKBR3 breast cancer cell line. Local targets link to admitted publications; unresolved targets remain external evidence.
A comprehensive review of HER2 in cancer biology and therapeutics
10.3390/genes15070903 · 2024 · External reference
Targeting HER2-positive breast cancer: advances and future directions
10.1038/s41573-022-00579-0 · 2023 · External reference
Targeting HER2 in solid tumors: unveiling the structure and novel epitopes
10.1016/j.ctrv.2024.102826 · 2024 · External reference
The role of HER2 in cancer therapy and targeted drug delivery
10.1016/j.jconrel.2010.04.009 · 2010 · External reference
Molecular targeting of the human epidermal growth factor receptor-2 (HER2) genes across various cancers
10.3390/ijms25021064 · 2024 · External reference
Human breast cancer: correlation of relapse and survival with amplification of the HER-2 / neu oncogene
10.1126/science.3798106 · 1987 · External reference
HER2 targeting peptides screening and applications in tumor imaging and drug delivery
10.7150/thno.14302 · 2016 · External reference
Evaluation of HER2-specific peptide ligand for its employment as radiolabeled imaging probe
10.1038/s41598-018-21283-3 · 2018 · External reference
Targeting EGFR/HER2/HER3 with a three-in-one aptamer-siRNA chimera confers superior activity against HER2+ breast Cancer
10.1016/j.omtn.2017.12.015 · 2018 · External reference
Targeting HER2 with DNA aptamers for efficient anticancer drug delivery: a combined experimental and computational study
10.1021/acs.bioconjchem.5c00022 · 2025 · External reference
Improved aptamers for the diagnosis and potential treatment of HER2-positive cancer
10.3390/ph9020029 · 2016 · External reference
Identification of novel HER2 inhibitors: potential therapeutics for breast cancer
10.1007/s12672-025-02792-w · 2025 · External reference
HER2 therapy. Small molecule HER-2 tyrosine kinase inhibitors
10.1186/bcr1652 · 2007 · External reference
Progress in peptide and protein therapeutics: challenges and strategies
10.1016/j.apsb.2025.10.026 · 2025 · External reference
Small molecule inhibitors targeting the cancers
2022 · External reference
10.1038/mtna.2014.32
10.1038/mtna.2014.32 · External reference
Aptamers as target-specific recognition elements in drug delivery
2025 · External reference
SELEXION. Systematic evolution of ligands by exponential enrichment with integrated optimization by non-linear analysis
10.1016/0022-2836(91)90509-5 · 1991 · External reference
Development and characterization of a DNA aptamer for MLL-AF9 expressing acute myeloid leukemia cells using whole cell-SELEX
10.1038/s41598-021-98676-4 · 2021 · External reference
Exploring the relationship between aptamer binding thermodynamics, affinity, and specificity
10.1093/nar/gkaf219 · 2025 · External reference
Selection of DNA aptamers for extra cellular domain of human epidermal growth factor receptor 2 to detect HER2 positive carcinomas
10.1007/s12094-017-1629-y · 2017 · External reference
Using aptamers for targeted delivery of RNA therapies
10.1016/j.ymthe.2025.02.047 · 2025 · External reference
Aptamer-based applications in delivering cancer gene therapies and beyond: state of the art and the missing links to clinical translation
10.1016/j.addr.2025.115639 · 2025 · External reference
Recent advancements of aptamers in Cancer therapy
10.1021/acsomega.3c04345 · 2023 · External reference
Therapeutic siRNA: state of the art
10.1038/s41392-020-0207-x · 2020 · External reference
The critical role of GRP78 in physiologic and pathologic stress
10.1016/j.ceb.2010.09.007 · 2011 · External reference
Glucose-regulated proteins in Cancer: molecular mechanisms and therapeutic potential
10.1038/nrc3701 · 2014 · External reference
Cancer-targeting peptides functionalized with polyarginine enables GRP78-dependent cell uptake and siRNA delivery within the DU145 prostate cancer cells
10.1002/psc.70007 · 2025 · External reference
RNAi screening of the glucose-regulated chaperones in cancer with self-assembled siRNA nanostructures
10.1021/acs.nanolett.6b02274 · 2016 · External reference
Supramolecular RNAi with multifunctional siRNA nanostructures
10.1039/d5bm01877c · 2026 · External reference
10.1007/978-1-0716-5257-2_17
10.1007/978-1-0716-5257-2_17 · External reference
Multivalent aptamer approach: designs, strategies, and applications
2022 · External reference
Circular dichroism and conformational polymorphism of DNA
10.1093/nar/gkp026 · 2009 · External reference
Circular dichroism spectroscopy of DNA: from duplexes to Quadruplexes
10.1002/chir.22064 · 2012 · External reference
Influences of ribonucleotide on a duplex conformation and its thermal stability: study with the chimeric RNA−DNA strands
10.1021/ja037314h · 2004 · External reference
Evolution of antisense oligonucleotides: navigating nucleic acid chemistry and delivery challenges
10.1080/17460441.2024.2440095 · 2025 · External reference
Cationic lipid nanoparticles for therapeutic delivery of siRNA and miRNA to murine liver tumor
10.1016/j.nano.2013.05.007 · 2013 · External reference
Role of the unfolded protein response, GRP78 and GRP94 in organ homeostasis
10.1002/jcp.24923 · 2015 · External reference
Reduction of GRP78 expression with siRNA activates unfolded protein response leading to apoptosis in HeLa cells
10.1016/j.abb.2007.09.004 · 2007 · External reference
The engineering challenges and opportunities when designing potent ionizable materials for the delivery of ribonucleic acids
10.1080/17425247.2022.2144827 · 2022 · External reference
Selective eradication of human non-small cell lung cancer cells using aptamer-decorated nanoparticles harboring a cytotoxic drug cargo
10.1038/s41419-019-1870-0 · 2019 · External reference
